Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Current Opinion in Hematology|August 13, 2016
Matched sibling donor hematopoietic stem cell transplantation for thalassemiaSurapol Issaragrisil, Chutima Kunacheewa
Best Practice & Research. Clinical Haematology|March 7, 2020
High-risk smoldering myeloma versus early detection of multiple myeloma: Current models, goals of therapy, and clinical implicationsChutima Kunacheewa, Elisabet E Manasanch
Annual Review of Medicine|January 30, 2019
New Drugs in Multiple MyelomaChutima Kunacheewa, Robert Z Orlowski
Expert Review of Hematology|September 22, 2021
The benefits of early intervention using lenalidomide for high-risk smoldering multiple myeloma: emerging data and its promising clinical impactChutima Kunacheewa, Elisabet E Manasanch
Journal of Medical Case Reports|January 12, 2022
Concurrent myasthenia gravis-related cervical thymoma in a patient with diffuse large B-cell lymphoma: a case reportChutima Kunacheewa, Sattawut Wongwiangjunt, Sanya Sukpanichnant
Leukemia & Lymphoma|October 25, 2022
The role of soluble B cell maturation antigen as a biomarker in multiple myelomaMohammed Alomari, Chutima Kunacheewa, Elisabet E Manasanch
Cell Transplantation|October 9, 2020
Post-Transplant Cyclophosphamide and Thymoglobulin, a Graft-Versus-Host Disease Prophylaxis in Matched Sibling Donor Peripheral Blood Stem Cell TransplantationsChutima Kunacheewa, Weerapat Owattanapanish, Chutirat Jirabanditsakul, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 8, 2021
The Real-Life Efficacy of Fixed-Dose Hypomethylating Agents in Older Patients With Acute Myeloid Leukemia: A 10-Year ExperienceTarinee Rungjirajittranon, Smith Kungwankiattichai, Chutima Kunacheewa, et al.
BMC Cancer|November 18, 2018
Risk of febrile neutropenia among patients with multiple myeloma or lymphoma who undergo inpatient versus outpatient autologous stem cell transplantation: a systematic review and meta-analysisWeerapat Owattanapanich, Kittima Suphadirekkul, Chutima Kunacheewa, et al.
Hematology (Amsterdam, Netherlands)|June 22, 2019
A systematic review and meta-analysis of the efficacy and adverse events of azacitidine-plus-lenalidomide treatment for patients with acute myeloid leukemia, myelodysplastic syndromes and chronic myelomonocytic leukemia 1Chutima Kunacheewa, Pakaporn Thongthang, Patompong Ungprasert, et al.
Pageof 2